Data as of Apr 16
| -1.59 / -2.02%|
The 2 analysts offering 12-month price forecasts for Furiex Pharmaceuticals Inc have a median target of 138.50, with a high estimate of 140.00 and a low estimate of 137.00. The median estimate represents a +79.59% increase from the last price of 77.12.
The current consensus among 2 polled investment analysts is to Buy stock in Furiex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.